Short-term outcome of take-home prescriptions for opioid dependence: a clinic-based study

References

• Bell, J., Shanahan, M., Mutch, C., Rea, F., Ryan, A., Batey, R., Dunlop, A., & Winstock, A. (2007). A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine–naloxone for heroin dependence. Addiction, 102, 1899–1907.
   PubMed Web of Science ®Google Scholar
• Boothby, L. A., & Doering, P. L. (2007). Buprenorphine for the treatment of opioid dependence. American Journal of Health-System Pharmacy, 64, 266–272.
   PubMed Web of Science ®Google Scholar
• Chand, P. K., & Murthy, P. (2003). Megadose lorazepam dependence. Addiction, 98, 1635–1636.
   PubMedGoogle Scholar
• Donaher, P. A., & Welsh, C. (2006). Managing opioid addiction with buprenorphine. American Family Physician, 73, 1573–1578.
   PubMed Web of Science ®Google Scholar
• Fals-Stewart, W., & O’Farrell, T. J. (2003). Behavioral family counseling and naltrexone for male opioid-dependent patients. Journal of Consulting and Clinical Psychology, 71, 432–442.
   PubMed Web of Science ®Google Scholar
• Gerra, G., Leonardi, C., D’Amore, A., Strepparola, G., Fagetti, R., Assi, C., Zaimovic, A., & Lucchini, A. (2006). Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study. Progress in neuro-psychopharmacology & biological psychiatry, 30, 265–272.
   PubMed Web of Science ®Google Scholar
• Goyal, V., Chawla, J. M., Balhara, Y. P., Shukla, G., Singh, S., & Behari, M. (2008). Calcific myofibrosis due to pentazocine abuse: A case report. Journal of Medical Case Reports, 2, 160.
   PubMedGoogle Scholar
• International Narcotics Control Board. Vienna, S. I. (2007). INCB. International Narcotics Control Board Report 2007. New York: United Nations.
   Google Scholar
• Johansson, B. A., Berglund, M., & Lindgren, A. (2006). Efficacy of maintenance treatment with naltrexone for opioid dependence: A meta-analytical review. Addiction, 101, 491–503.
   PubMed Web of Science ®Google Scholar
• Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000). A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. The New England Journal of Medicine, 343, 1290–1297.
   PubMed Web of Science ®Google Scholar
• Johnson, R. E., Jaffe, J. H., & Fudala, P. J. (1992). A controlled trial of buprenorphine treatment for opioid dependence. JAMA, 267, 2750–2755.
   PubMed Web of Science ®Google Scholar
• Kumar, M. S., Natale, R., Langkham, B., Sharma, C., Kabi, R., & Mortimore, G. (2009). Opioid substitution treatment with sublingual buprenorphine in Manipur and Nagaland in Northeast India: What has been established needs to be continued and expanded. Harm Reduction Journal, 6, 456–465.
   Google Scholar
• Larance, B., Ambekar, A., Azim, T., Murthy, P., Panda, S., Degenhardt, L., & Mathers, B. (2011). The availability, diversion and injection of pharmaceutical opioids in South Asia. Drug and Alcohol Review, 30, 246–254.
   PubMed Web of Science ®Google Scholar
• Ling, W., Rawson, R. A., & Compton, M. (2003). Clinical treatment of opioid addiction and dependence. Methods in Molecular Medicine, 84, 285–295.
   PubMedGoogle Scholar
• Mattick, R. P., Ali, R., White, J. M., O’Brien, S., Wolk, S., & Danz, C. (2003). Buprenorphine versus methadone maintenance therapy: A randomized double-blind trial with 405 opioid-dependent patients. Addiction, 98, 441–452.
   PubMed Web of Science ®Google Scholar
• Mattick, R. P., Digiusto, E., Doran, C., O’Brien, S., Shanahan, M., Kimber, J., Henderson, N., Breen, C., Shearer, J., Gates, J., Shakeshaft, A., & Investigators*, N. T. (2001). National Evaluation of Pharmacotherapies for Opioid Dependence: Report of Results and Recommendations. Sydney: National Drug and Alcohol Research Centre.
   Google Scholar
• Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2002). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. The Cochrane Database of Systematic Reviews (3), CD002207.
   Google Scholar
• Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2004). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. The Cochrane Database of Systematic Reviews (3), CD002207.
   Google Scholar
• Mohan, D., Dhawan, A., Chopra, A., & Sethi, H. (2006). A 24-week outcome following buprenorphine maintenance among opiate users in India. Journal of Substance Use, 11, 409–415.
   Google Scholar
• Moore, B. A., Fiellin, D. A., Barry, D. T., Sullivan, L. E., Chawarski, M. C., O’Connor, P. G., & Schottenfeld, R. S. (2007). Primary care office-based buprenorphine treatment: Comparison of heroin and prescription opioid dependent patients. Journal of General Internal Medicine, 22, 527–530.
   PubMed Web of Science ®Google Scholar
• Murthy, P. (2008). Women and drug use in India: Substance, women and high-risk assessment study. New Delhi: United Nations Office on Drugs and Crime: Regional office South Asia.
   Google Scholar
• Murthy, P., Chand, P., Harish, M., Thennarasu, K., Prathima, S., Karappuchamy, & Janakiramiah, N. (2009). Outcome of alcohol dependence: The role of continued care. Indian Journal of Community Medicine, 34, 148–151.
   PubMedGoogle Scholar
• Nattala, P., Leung, K. S., Nagarajaiah, M. P., & Murthy, P. (2010). Family member involvement in relapse prevention improves alcohol dependence outcomes: A prospective study at an addiction treatment facility in India. Journal of Studies on Alcohol and Drugs, 71, 581–587.
   PubMed Web of Science ®Google Scholar
• Ray, R. (2004). Substance abuse and the growth of de-addiction centres: The challenge of our times. In S. P. Agarwal ( Ed.), Mental health: An Indian perspective 1946–2003 ( pp. 284–289). New Delhi: Elsevier.
   Google Scholar
• Schottenfeld, R. S., Chawarski, M. C., & Mazlan, M. (2008). Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: A randomised, double-blind, placebo-controlled trial. Lancet, 371, 2192–2200.
   PubMed Web of Science ®Google Scholar
• Schottenfeld, R. S., Pakes, J. R., Oliveto, A., Ziedonis, D., & Kosten, T. R. (1997). Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Archives of general psychiatry, 54, 713–720.
   PubMed Web of Science ®Google Scholar
• Sharma, M., Oppenheimer, E., Saidel, T., Loo, V., & Garg, R. (2009). A situation update on HIV epidemics among people who inject drugs and national responses in South-East Asia Region. AIDS, 23, 1405–1413.
   PubMed Web of Science ®Google Scholar
• Stoller, K. B., Bigelow, G. E., Walsh, S. L., & Strain, E. C. (2001). Effects of buprenorphine/naloxone in opioid-dependent humans. Psychopharmacology (Berl), 154, 230–242.
   PubMed Web of Science ®Google Scholar
• Sung, S., & Conry, J. M. (2006). Role of buprenorphine in the management of heroin addiction. The Annals of Pharmacotherapy, 40, 501–505.
   PubMedGoogle Scholar
• Thirthalli, J., & Chand, P. K. (2009). The implications of medication development in the treatment of substance use disorders in developing countries. Current Opinion in Psychiatry, 22, 274–280.
   PubMedGoogle Scholar
• United Nations. (2004). Substance abuse treatment and care for women: Case studies and lessons learned. New York: United Nation Office on Drug and Crime. ISBN 92-1-148194-5.
   Google Scholar
• van den Brink, W., & van Ree, J. M. (2003). Pharmacological treatments for heroin and cocaine addiction. European Neuropsychopharmacology, 13, 476–487.
   PubMed Web of Science ®Google Scholar
• Varescon, I., Vidal-Trecan, G., Nabet, N., & Boissonnas, A. (2002). Buprenorphine abuse: High dose intravenous administration of buprenorphine. Encephale, 28, 397–402.
   PubMed Web of Science ®Google Scholar